Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Nonproliferative Diabetic Retinopathy”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Post-approval studies (Phase 4)WithdrawnNCT04702048
What this trial is testing

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Who this might be right for
Retinopathy, Diabetic
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT04692688
What this trial is testing

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more
Ocuphire Pharma, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)Ended earlyNCT00248131
What this trial is testing

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 260
Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06321302
What this trial is testing

Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 187
Large-scale testing (Phase 3)Enrolling By InvitationNCT06951087
What this trial is testing

Intravitreal and Intracameral DEX in NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Affiliated Hospital of Nantong University 80
Testing effectiveness (Phase 2)Study completedNCT00198471
What this trial is testing

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

Who this might be right for
Vitreous DetachmentDiabetic Retinopathy
Bausch & Lomb Incorporated 10
Testing effectiveness (Phase 2)Study completedNCT00917553
What this trial is testing

Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Thomas Gardner 33
Not applicableStudy completedNCT05543564
What this trial is testing

Prophylactic PRP in Moderate NPDR

Who this might be right for
Eye DiseasesDiabetesDiabetic Retinopathy
Assiut University 68
Not applicableStudy completedNCT03696810
What this trial is testing

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Who this might be right for
NPDR - Non Proliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 141
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Post-approval studies (Phase 4)UnknownNCT04283162
What this trial is testing

Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Zhongda Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT04722991
What this trial is testing

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Who this might be right for
Diabetic Retinopathy
Bayer 109
Testing effectiveness (Phase 2)Study completedNCT05383209
What this trial is testing

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00511875
What this trial is testing

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Thomas Gardner 30
Early research (Phase 1)UnknownNCT05695417
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 21
Not applicableEnded earlyNCT01880372
What this trial is testing

The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

Who this might be right for
Moderate Non-proliferative Diabetic Retinopathy
Ferris State University 1
Load More Results